Evidence map›Paper›PMID 37662411›Full record

ArticlebioRxiv : the preprint server for biology2023

Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.

Katherine M Weh, Connor L Howard, Yun Zhang, Bridget A Tripp, Jennifer L Clarke, Amy B Howell, Joel H Rubenstein, Julian A Abrams, Maria Westerhoff, Laura A Kresty

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jennifer L ClarkeORCID 0000-0002-2723-7249
Joel H Rubenstein
Julian A Abrams
Maria Westerhoff
University of Michigan · USUniversity of Nebraska–Lincoln · USColumbia University Irving Medical Center · USRutgers, The State University of New Jersey · US

Funding

Inhibition of Reflux-Induced Esophageal Adenocarcinoma by ProanthocyanidinsR01CA158319 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRESTY, LAURA A · 2012 to 2016
$1.6M
NCI NIH HHS R01 CA158319
6 · The paper itself

Abstract

The gut and local esophageal microbiome progressively shift from healthy commensal bacteria to inflammatory-linked pathogenic bacteria in patients with gastroesophageal reflux disease, Barrett's esophagus and esophageal adenocarcinoma (EAC). However, mechanisms by which microbial communities and metabolites contribute to reflux-driven EAC remain incompletely understood and challenging to target. Herein, we utilized a rat reflux-induced EAC model to investigate targeting the gut microbiome-esophageal metabolome axis with cranberry proanthocyanidins (C-PAC) to inhibit EAC progression. Sprague Dawley rats, with or without reflux-induction received water or C-PAC

Identifiers

PMID37662411
PMCPMC10473615
OpenAlexW4386085680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.